6EYF
Butyrylcolinesterase expressed in CHO cells co-crystallised with a rivastigmine analogue
Replaces: 6EULSummary for 6EYF
Entry DOI | 10.2210/pdb6eyf/pdb |
Descriptor | Cholinesterase, 2-acetamido-2-deoxy-beta-D-glucopyranose, [3-[(1~{R})-1-(dimethylamino)ethyl]-4-oxidanyl-phenyl] ~{N}-ethyl-~{N}-methyl-carbamate, ... (6 entities in total) |
Functional Keywords | butyrylcholinesterase, alzheimer disease, organophosphate, carbamylated, rivastigmine analogue, rational design, hydrolase |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 1 |
Total formula weight | 61113.92 |
Authors | Brazzolotto, X.,De la Mora, E.,Dighe, S.,Ross, B. (deposition date: 2017-11-12, release date: 2018-11-21, Last modification date: 2024-01-17) |
Primary citation | Dighe, S.,De la Mora, E.,Chan, S.,Kantham, S.,McColl, G.,Veliyath, S.K.,Miles, J.A.,Nessar, Z.Y.,Mcgeary, R.,Silman, I.,Weik, I.,Parat, M.O.,Brazzolotto, X.,Ross, B. Rivastigmine and metabolite analogues with putative Alzheimer's disease-modifying properties in a Caenorhabditis elegans model Commun Chem, 2019 Cited by DOI: 10.1038/s42004-019-0133-4PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.6 Å) |
Structure validation
Download full validation report